Understanding how prolactin-producing pituitary tumours are diagnosed is crucial for anyone experiencing unexplained symptoms like irregular periods, fertility problems, or unusual milk production. While these noncancerous growths can feel worrying, accurate diagnostic testing paves the way for effective treatment and helps restore normal hormone levels and quality of life.

Introduction: When to Seek Diagnostic Testing

If you notice changes in your body that seem unusual or unexplained, it might be time to consider diagnostic testing for a prolactin-producing pituitary tumour. Women who experience irregular menstrual periods, absence of periods not related to menopause, or milky discharge from the breasts when not pregnant or breastfeeding should consult their doctor. These symptoms often prompt earlier medical attention in women compared to men, which can lead to quicker diagnosis and treatment.^[1]

Men should seek medical advice if they develop erectile dysfunction, reduced interest in sex, infertility, or enlarged breast tissue. Both men and women may experience headaches or vision problems if the tumour grows large enough to press on surrounding structures. These symptoms deserve prompt medical evaluation because they may indicate a larger tumour affecting nearby tissues.^[2]

People taking certain medications should also be aware that some drugs can raise prolactin levels. Anti-sickness medications like metoclopramide or domperidone, some antidepressants like fluoxetine, and even acid-reducing medications can cause elevated prolactin. If you’re on these medications and develop symptoms, your doctor will need to determine whether the symptoms stem from medication or an actual tumour.^[4]

Sometimes prolactinomas are discovered accidentally during brain imaging for unrelated reasons. Many people have small, symptom-free prolactinomas that never cause problems and don’t require treatment. However, if symptoms develop or if routine blood work shows unexpectedly high prolactin levels, further diagnostic investigation becomes necessary.^[3]

Classic Diagnostic Methods for Identifying Prolactinomas

The diagnostic journey for a prolactin-producing pituitary tumour typically begins with a thorough conversation between you and your healthcare provider. Your doctor will ask detailed questions about your symptoms, medical history, and any medications you’re currently taking. This initial discussion helps identify patterns that might suggest a prolactinoma or rule out other causes of elevated prolactin levels.^[2]

A physical examination follows the medical history. If you’re experiencing milky nipple discharge, your doctor may perform a breast examination. The physical exam helps identify any other signs that might point toward hormonal imbalances or tumor-related complications. This step is particularly important because many conditions can mimic prolactinoma symptoms, and a careful examination helps narrow the possibilities.^[2]

Blood Tests: The Foundation of Diagnosis

The most crucial diagnostic tool for identifying a prolactinoma is a prolactin blood test. This simple blood draw measures the amount of prolactin hormone circulating in your bloodstream. A normal prolactin level is typically less than 20 nanograms per milliliter. When levels rise above normal, it signals that something may be affecting prolactin production or regulation.^[24]

Understanding prolactin levels requires expertise because different levels suggest different conditions. Slightly elevated prolactin might result from stress during the blood draw, certain medications, an underactive thyroid, or other benign causes. However, when prolactin levels exceed 150 to 200 nanograms per milliliter, this strongly indicates the presence of a prolactinoma. The higher the prolactin level, the larger the tumour typically is.^[24]

Your doctor will likely order additional blood tests to evaluate other pituitary hormones. These tests check whether the pituitary gland is functioning properly in producing other essential hormones like thyroid-stimulating hormone, growth hormone, and hormones that regulate the adrenal glands and reproductive system. Testing these other hormones helps determine whether a growing tumour has affected normal pituitary function by compressing healthy tissue.^[9]

Specialized blood testing may be necessary in some cases. A condition called macroprolactinemia can artificially elevate prolactin measurements without causing symptoms. This occurs when prolactin binds to certain blood proteins, creating a false impression of high prolactin levels. Specialized testing can distinguish true elevation from this benign laboratory artifact, preventing unnecessary treatment.^[4]

Thyroid function tests are particularly important because an underactive thyroid gland can mimic a prolactinoma by raising prolactin levels. This condition, sometimes called pseudoprolactinoma, resolves when the thyroid problem is treated. Testing thyroid function ensures that doctors don’t mistake a thyroid disorder for a pituitary tumour.^[8]

Brain Imaging: Visualizing the Tumour

Once blood tests confirm elevated prolactin levels, brain imaging becomes the next critical step. A magnetic resonance imaging (MRI) scan of the brain and pituitary gland provides detailed pictures that can reveal the presence, size, and location of a prolactinoma. MRI is the preferred imaging method because it offers superior visualization of soft tissues compared to other scanning techniques.^[2]

The MRI helps doctors classify the tumour by size, which influences treatment decisions. Tumours smaller than 1 centimeter (about 3/8 of an inch) in diameter are called microprolactinomas. These represent at least half of all prolactinoma cases and are more common in women. Tumours larger than 1 centimeter are called macroprolactinomas, which tend to occur more frequently in men and at older ages.^[2]

In situations where MRI cannot be performed—for example, if you have certain metal implants or severe claustrophobia—a computed tomography (CT) scan may be used as an alternative. While not as detailed as MRI for pituitary visualization, CT scans can still provide valuable information about tumour size and location.^[8]

Imaging also reveals whether the tumour is pressing on nearby structures, particularly the optic nerves that control vision. Large prolactinomas can extend upward from the pituitary gland and compress the optic chiasm, the point where the optic nerves cross. This compression can cause vision problems, making imaging assessment crucial for treatment planning.^[7]

Vision Testing: Assessing Tumour Impact

Vision tests may be recommended, especially if imaging shows that the tumour is large enough to potentially affect the optic nerves. These tests evaluate your visual fields—the full area you can see when looking straight ahead. A large prolactinoma pressing on the optic nerves typically causes loss of peripheral (side) vision first, creating what doctors call “tunnel vision.”^[1]

Vision testing establishes a baseline that helps track whether the tumour is affecting sight and whether treatment is improving or preventing vision problems. Regular vision assessments may continue during treatment to ensure that visual function is preserved or restored.^[9]

Distinguishing Prolactinomas from Other Conditions

An essential aspect of diagnosis involves ruling out other causes of elevated prolactin. Pregnancy is an important consideration in women of childbearing age, as prolactin naturally rises during pregnancy. A pregnancy test is typically performed as part of the diagnostic evaluation.^[9]

Certain medications can raise prolactin levels and must be considered before diagnosing a prolactinoma. Drugs used to treat nausea, psychiatric conditions, high blood pressure, and heartburn can all elevate prolactin. Your doctor will carefully review your medication list to determine whether drug-induced elevation might explain your symptoms.^[4]

Other pituitary tumours can also cause prolactin elevation through a mechanism called the “stalk effect.” When a non-prolactin-producing tumour compresses the pituitary stalk—the connection between the brain and pituitary gland—it can interfere with dopamine delivery. Since dopamine normally suppresses prolactin production, its absence causes prolactin to rise. However, stalk effect typically causes only modest prolactin elevation, usually less than 100 nanograms per milliliter, helping distinguish it from a true prolactinoma.^[3]

Diagnostics for Clinical Trial Qualification

When people with prolactinomas are being considered for participation in clinical trials testing new treatments, additional or more frequent diagnostic procedures may be required. Clinical trials follow strict protocols to ensure that participants are appropriate candidates and to accurately measure how well new treatments work.^[6]

Blood prolactin measurements form the core of clinical trial screening and monitoring. Trials typically require documentation of elevated prolactin levels measured at specific time points before treatment begins. Some trials may specify minimum prolactin levels for participation, ensuring that enrolled patients have significant hormone elevation that might benefit from the experimental treatment. Repeated prolactin measurements throughout the trial help researchers track how well the new treatment controls hormone levels compared to standard therapies.^[6]

Comprehensive pituitary hormone panels are standard in clinical trials. These tests measure not just prolactin but also thyroid function, cortisol levels, growth hormone, and reproductive hormones. This complete hormone assessment establishes baseline pituitary function and helps identify any additional hormone deficiencies that might affect trial participation or require management during the study.^[6]

MRI scans serve multiple purposes in clinical trial settings. An initial MRI confirms the presence and documents the exact size and characteristics of the prolactinoma. Trials testing new treatments often require follow-up MRI scans at predetermined intervals—perhaps every three months, six months, or yearly—to measure whether the tumour shrinks, remains stable, or grows. Standardized MRI protocols ensure that scans can be accurately compared over time and across different medical centers participating in the trial.^[6]

Vision assessments may be more detailed and frequent in clinical trials, especially for patients with large tumours near the optic nerves. Formal visual field testing at regular intervals helps detect any improvement or deterioration in vision that might result from tumour size changes during experimental treatment.^[6]

Clinical trials may also include quality of life questionnaires and symptom assessment scales. These tools systematically track symptoms like headaches, sexual function, menstrual regularity, and overall well-being. Standardized questionnaires allow researchers to objectively measure whether new treatments improve not just hormone levels and tumour size but also the symptoms and quality of life issues that matter most to patients.^[6]

Additional testing requirements vary depending on the specific trial and the treatment being studied. Some trials might require bone density scans to assess whether untreated high prolactin has caused bone loss, then measure whether treatment reverses this problem. Others might include fertility assessments for participants hoping to conceive, tracking whether new treatments successfully restore reproductive function.^[6]

Safety monitoring is intensified in clinical trials compared to standard care. This means more frequent blood tests to check for potential side effects of experimental treatments, monitoring liver and kidney function, and watching for any unexpected effects on blood counts or other body systems. While this increased testing requires more time and commitment from participants, it ensures their safety and provides valuable data about new treatment options.^[6]